Global Soft Tissue Repair Market is Expected to $14.7 Billion in 2019

Date: 2015-08-20

“Soft tissue repair products are used to repair and reconstruct soft tissue injuries. The soft tissue repair market is mainly driven by technological advancements, innovative product offerings, increasing incidence of soft tissue injuries among the aging population, increasing participation in sports, and the increasing obesity rate. However, the ambiguity in reimbursement for these products and the increasing cost of surgical procedures are expected to restrain the growth of this market in the forecast period. 

The market in this report is broadly segmented on the basis of products and applications. The market, by products, is segmented into tissue patches/meshes, soft tissue fixation devices, and laparoscopic instruments. On the basis of application, the market is segmented into hernia repair, dural repair, vaginal sling procedures, skin repair, orthopedic soft tissue repair, dental soft tissue repair, and breast reconstruction repair. 

The global soft tissue repair market is expected to grow at a CAGR of 7.5% during the forecast period of 2014 to 2019 to reach $14.7 billion in 2019. Soft tissue repair procedures are increasingly being conducted to repair orthopedic soft tissue tears, herniation, and breast reconstruction; this is driving market growth. In addition to this, heavy investments by key manufacturers to offer advanced and innovative products for better results are also propelling market growth. 

Developed regions like North America and Europe will show sluggish growth, while emerging markets like Asia-Pacific and RoW (Latin America) are expected to record strong growth. Growth will be centered on countries like India, China, and Brazil owing to rising investments by public and private players in these countries, the presence of a large patient population, and the focus of leading players to capture growth opportunities in these markets. 

Some prominent players in this market include LifeCell Corporation (U.S.), Organogenesis (U.S.), C.R. Bard, Inc. (U.S.), Johnson & Johnson (U.S.), Covidien plc (Ireland), Arthrex, Inc. (U.S.), Smith & Nephew plc (U.K.), Integra Lifesciences Corporation (U.S.), Wright Medical Technology (U.S.), and Stryker Corporation (U.S.).

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample